What is Lifesci Capital’s Forecast for TARA Q1 Earnings?
Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) – Investment analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Protara Therapeutics in a note issued to investors on Tuesday, March 11th. Lifesci Capital analyst C. Zhu expects that the company will earn ($0.37) per share for the quarter. Lifesci Capital currently has a “Outperform” […]
Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) – Investment analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Protara Therapeutics in a note issued to investors on Tuesday, March 11th. Lifesci Capital analyst C. Zhu expects that the company will earn ($0.37) per share for the quarter. Lifesci Capital currently has a “Outperform” […]
